期刊论文

中文

中医药导报

1672-951X

2001

7

2

48-50

10.13862/j.cnki.cn43-1446/r.2001.02.002

湖南省卫生厅中医药科研基金资助项目! （编号 960 2 9）；

本校为第一机构

采用头痛康颗粒剂治疗偏头痛(治疗组)45例,并与Ca2+拮抗剂西比灵(对照组)进行随机对照,结果表明:①头痛康颗粒剂和西比灵均能降低每月头痛发作的频度、缩短头痛持续时间、减轻头痛强度、降低头痛指数,但治疗组的作用优于对照组(P＜0.05或P＜0.01);②头痛康颗粒剂治疗偏头痛的临床愈显率明显高于对照组(P＜0.01),临床疗效明显优于对照组(P＜0.01).

Objecfive:To observe the therapeutic effects of Toutongkang granules on migraine. Methods:90 cases of migraine were randomly divided into Toutongkang group (treatment group, 45 cases) and Xibiling (due to Ca 2+ antagonism) group (control group, 45,cases),and their therapeutic effects were compared. Results:Both groups can reduce the frequency, the continuous time, the intensity and the index of migraine, but the effect of treatment group was better than the control group (P